We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+7.96%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$78.8B
AUM Growth
-$135M
(-0.17%)
Cap. Flow
-$4.13B
Cap. Flow
% of AUM
-5.25%
Top 10 Holdings %
Top 10 Hldgs %
14.64%
Holding
3,669
New
809
Increased
1,002
Reduced
1,102
Closed
643
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$807M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$497M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$390M |
| 4 |
Kenvue
KVUE
|
+$379M |
| 5 |
Broadcom
AVGO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$409M |
| 2 |
Visa
V
|
+$354M |
| 3 |
Advanced Micro Devices
AMD
|
+$328M |
| 4 |
Meta Platforms (Facebook)
META
|
+$317M |
| 5 |
Lockheed Martin
LMT
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.61% |
| 2 | Consumer Discretionary | 9.64% |
| 3 | Healthcare | 8.17% |
| 4 | Industrials | 8.1% |
| 5 | Financials | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Coastal Financial
CCB
$754M
| $294K | ﹤0.01% |
2,567
+357
| +16% | +$39K |
|
2677
Quest Diagnostics
DGX
$26.2B
| $294K | ﹤0.01% |
1,695
-219,808
| -99% | -$40M |
|
2678
Delek US
DK
$4.12B
| $294K | ﹤0.01% |
+9,908
| New | +$354K |
|
2679
Principal Financial Group
PFG
$24.4B
| $294K | ﹤0.01% |
+3,331
| New | +$281K |
|
2680
Intercorp Financial Services
IFS
$6.09B
| $294K | ﹤0.01% |
+6,935
| New | +$285K |
|
2681
PUT
MP Materials
MP
$9.64B
| $293K | ﹤0.01% |
+5,800
| New | +$368K |
|
2682
SK Telecom
SKM
$13.5B
| $293K | ﹤0.01% |
+14,263
| New | +$293K |
|
|
MOMO
2683
Hello Group
MOMO
$867M
| $293K | ﹤0.01% |
44,689
+33,392
| +296% | +$230K |
|
2684
PUT
Atlassian
TEAM
$39.4B
| $292K | ﹤0.01% |
1,800
-7,100
| -80% | -$1.11M |
|
2685
Inseego
INSG
$82.6M
| $292K | ﹤0.01% |
28,406
-496,231
| -95% | -$6.44M |
|
2686
AngloGold Ashanti
AU
$49.5B
| $291K | ﹤0.01% |
+3,407
| New | +$266K |
|
2687
International Bancshares
IBOC
$4.52B
| $290K | ﹤0.01% |
4,370
-1,223
| -22% | -$82.8K |
|
2688
Compass Minerals
CMP
$1.12B
| $290K | ﹤0.01% |
+14,746
| New | +$273K |
|
2689
PUT
CleanSpark
CLSK
$3.13B
| $288K | ﹤0.01% |
+28,500
| New | +$427K |
|
2690
PUT
Rio Tinto
RIO
$165B
| $288K | ﹤0.01% |
+3,600
| New | +$259K |
|
2691
Amcor
AMCR
$21.5B
| $288K | ﹤0.01% |
+6,909
| New | +$285K |
|
2692
Genuine Parts
GPC
$18.5B
| $286K | ﹤0.01% |
2,325
-440,103
| -99% | -$57M |
|
2693
Universal Health Services
UHS
$10.2B
| $285K | ﹤0.01% |
1,309
-59
| -4% | -$13K |
|
|
TWFG
2694
TWFG Inc
TWFG
$1.44B
| $285K | ﹤0.01% |
+9,890
| New | +$269K |
|
2695
PUT
The Mosaic Company
MOS
$7.18B
| $284K | ﹤0.01% |
11,800
-2,100
| -15% | -$56.6K |
|
2696
Vanguard Dividend Appreciation ETF
VIG
$115B
| $283K | ﹤0.01% |
+1,288
| New | +$281K |
|
2697
Hercules Capital
HTGC
$3.11B
| $282K | ﹤0.01% |
15,002
-4,265
| -22% | -$76.9K |
|
2698
Eastman Chemical
EMN
$8.29B
| $281K | ﹤0.01% |
4,398
+678
| +18% | +$41.8K |
|
2699
Trimble
TRMB
$13.1B
| $279K | ﹤0.01% |
3,561
-35,699
| -91% | -$2.84M |
|
2700
PUT
Alnylam Pharmaceuticals
ALNY
$30B
| $278K | ﹤0.01% |
+700
| New | +$310K |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q4 2025 Portfolio in Review
As of Q4 2025, Balyasny Asset Management held 3,669 positions worth $78.8B, down 0.17% from $78.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Balyasny Asset Management withdrew a net $4.13B in Q4 2025, closing 643 positions and reducing 1,102 holdings. Its most notable exit was Mr. Cooper, an estimated $277M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Balyasny Asset Management opened a new position in Avidity Biosciences worth $436M.
- Balyasny Asset Management's largest Q4 2025 buy was Avidity Biosciences: 6,040,590 shares worth $436M.
- Balyasny Asset Management added most to Amazon in Q4 2025, an estimated $807M increase.
- Balyasny Asset Management's biggest Q4 2025 reduction was Apple, cutting an estimated $409M.
- Balyasny Asset Management fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
- Balyasny Asset Management's ten largest holdings make up 15% of its $78.8B portfolio in Q4 2025.
- Balyasny Asset Management opened 809 new positions and closed 643 in Q4 2025.
- Balyasny Asset Management's portfolio value fell 0.17% quarter-over-quarter to $78.8B.
Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.